Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Fujirebio and Eisai partner to develop blood tests for diagnosing Alzheimer's and other neurodegenerative diseases.
Fujirebio and Eisai have agreed to collaborate on research and development of blood-based biomarkers for diagnosing neurodegenerative diseases, including Alzheimer's.
They plan to develop and commercialize diagnostic tools for proteins like p-Tau217 and simplify diagnostic methods.
This partnership aims to enhance global access to new diagnostic technologies, improving disease diagnosis and treatment.
5 Articles
Fujirebio y Eisai se asocian para desarrollar análisis de sangre para diagnosticar la enfermedad de Alzheimer y otras enfermedades neurodegenerativas.